The United States diabetes drugs market size is projected to exhibit a growth rate (CAGR) of 3.55% during 2025-2033. The ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...

Managing type 1 diabetes isn’t just about insulin. Find out how men can overcome the mental hurdles and build a healthier, more resilient life.

Discover expert tips from an obesity medicine doctor on effective and sustainable ways to approach weight loss for type 2 diabetes.

Originally developed for patients with diabetes, continuous glucose monitors have the potential to improve earlier stages of blood glucose dysfunction, too.

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a ...

TORONTO, May 28, 2025 /CNW/ - Diabetes Express, a division of Bayshore HealthCare, is proud to sponsor "Cycle for Type 1" a coast-to-coast cycling journey undertaken by an individual with type 1 ...

PurpleLab and Genentech executives will explore how to leverage real world data to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical ...

Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for ...

To register for the webinar Eliminating Blind Spots in the Patient Journey, scheduled for 1-2 pm ET on May 22, please fill out the form below: Photo:Eugene Mymrin, Getty Images ...